Molnupiravir for Home

Epicentre News • 08 March 2022

There’s a gap between those that battle with COVID and those that battle enough to need hospital care. So there is a need for new treatments that can reduce the risk of COVID-19 progressing.

What is Molnupiravir?

Molnupiravir is an oral, antiviral medication that stops the replication of certain RNA viruses. It is used to treat COVID-19 in those infected.

What Do Studies Say?

In a very recent study was published in the New England Journal of Medicine, this study aimed to better understand how effective Molnupiravir was at treating COVID-19 patients at home. A total of, 1433 participants underwent randomization; 716 were assigned to receive Molnupiravir and 717 to receive a placebo.

This study found that Molnupiravir was successful in reducing the risk of hospitalization for any cause or death through day 29. Of the 385 participants, only 28 [7.3%] had a serious infection, this is better than with compared to the results of the placebo which had serious cases in 53 of 377 analysed [14.1%].

What was Interesting About This Study?

Only patients not vaccinated against Covid-19 were eligible for the trial, a choice made both to focus on those most likely to need antiviral treatment and to facilitate more rapid evaluation of the therapeutic efficacy of Molnupiravir.

Was This Study Trustworthy?

This study was randomized, which means the participants were chosen at random. This means that the study team couldn’t just choose particular people

There was a placebo group which they could compare their results to. A placebo group means that a group of children who were randomly selected to get a fake vaccine that does not contain the vaccine.

A placebo group helps to show what the effect of the vaccine actually is when compared with someone who didn’t actually get the medicine, although they thought they did.

Who Is Epicentre Health Research?

We’re an NGO with 21 years of expertise in the South African health research industry.

Our Guarantee is evidence based, structured & planned, electronically executed, monitored & evaluated, and customized to meet each research project’s needs.

Why Experts Think Paxlovid Will Help You Beat COVID

The World Health Organization (WHO) has just made a strong recommendation for, Pfizer’s new COVID antiviral pill, sold under the name, Paxlovid. They are presenting evidence that this pill can help those at risk of a bad infection make a full recovery.

Like Our Articles?

If you want to read more articles like this, join our monthly newsletter! We release insider info on what the health research industry is taking a look at each month.

Book with Epicentre

For 20 years Epicentre has been fighting South African’s infectious diseases, and now we’re taking on COVID-19! We are a company founded on a vision, ending disease in South Africa! So we believe in making an IMPACT.

We are an independent organization that is committed to creating a positive impact on health & wellness for all in South Africa.

We want to close the gap between unscreened, undiagnosed, and uncontrolled HIV & COVID-19 infections as well as other chronic diseases for all South Africans.

By booking your tests with Epicentre, you are supporting a real local company that has worked for 20 years in all 9 provinces, from Pollsmoor prison to Constantia; & you’re getting a gold standard service that experts trust!

Epicentre offers:

(R250 with a R50 pensioners discount!)

(PCR Flight certificate in 24-36hrs)


(R1150 + travel over 50kms)

(PCR Flight certificate in 12hrs)


Cape Town Only

(PCR Flight certificate in 4-5hrs)


Cape Town Only

(PCR + Antiviral Mask)


Contact Us

Ready to talk? Contact us today for a free consultation!